You are here
ABZYME THERAPEUTICS LLC
UEI: H2MLEFWV36N6
# of Employees: 8
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
High throughput camelid antibody screening as a drug discovery platform
Amount: $1,670,345.00ABSTRACTMonoclonal antibodies are used for treatment of a wide range of diseases from cancer to infectious diseasesHoweverdevelopment of antibodies with high affinity and specificity is still timecons ...
SBIRPhase II2016Department of Health and Human Services National Institutes of Health -
Single domain antibodies as medical countermeasures for viral induced encephalitis
Amount: $149,656.60Alphavirus infection, which may cause encephalitis and death, are recognized as potential biological warfare agents. There are no approved medical countermeasures against diseases caused by Alphavirus ...
SBIRPhase I2016Department of Defense Office for Chemical and Biological Defense -
An Instant Estrogen Sensor for Poultry Gender Sorting Automation
Amount: $99,943.00The need for segregation of poultry based on sex is driven by gender-related differences in growth rate, market age, management practices, and nutritional requirements. Each day, global poultry indust ...
SBIRPhase I2015Department of Agriculture -
Hybridoma-free multiplex approach for accelerating mouse monoclonal antibody generation
Amount: $264,747.00DESCRIPTION provided by applicant Thanks to their exquisite specificity and sensitivity monoclonal antibodies Mab are the most important research tool for detection localization and quantificat ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Nanobodies for topical delivery to inhibit abnormal choroidal angiogenesis
Amount: $224,935.00DESCRIPTION provided by applicant The age related macular degeneration AMD characterized by the formation of subretinal choroidal neovascularization is the main cause of blindness in the elderly ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
High throughput approach for generating human monoclonal antibodies
Amount: $224,799.00DESCRIPTION provided by applicant Thanks to their exquisite specificity and sensitivity monoclonal antibodies Mab have found a broad application in research diagnosis and therapy For treatment ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Novel bispecific T cell engaging antibodies for treatment of Lyme disease
Amount: $224,849.00DESCRIPTION (provided by applicant): Lyme disease (LD) is the most commonly reported tick-borne illness in the United States. According to the recent Center for Disease Control and Prevention report, ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Nanobodies for detecting and manipulating A to I editing enzymes and their modified RNA products
Amount: $224,975.00DESCRIPTION (provided by applicant): Adenosine to inosine or A-to-I RNA editing executed by ADAR family proteins is abundant in the central nervous system (CNS). The availability of tools to monitor a ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
High throughput camelid antibody screening as drug discovery platform
Amount: $218,085.00DESCRIPTION (provided by applicant): Monoclonal antibodies are used for treatment of a wide range of diseases from cancer to infectious diseases. However, development of antibodies with high affinity ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Low cost approach for production of sweet proteins as sugar substitutes
Amount: $99,973.00In a large portion of the population the strong desire to eat sweet foods is a major contributing factor leading to overweightness and obesity, and the concomitant predisposition to diabetes diseases. ...
SBIRPhase I2014Department of Agriculture
